1. Home
  2. SLS vs SUPX Comparison

SLS vs SUPX Comparison

Compare SLS & SUPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLS
  • SUPX
  • Stock Information
  • Founded
  • SLS 2012
  • SUPX 2021
  • Country
  • SLS United States
  • SUPX Singapore
  • Employees
  • SLS N/A
  • SUPX N/A
  • Industry
  • SLS Biotechnology: Pharmaceutical Preparations
  • SUPX
  • Sector
  • SLS Health Care
  • SUPX
  • Exchange
  • SLS Nasdaq
  • SUPX Nasdaq
  • Market Cap
  • SLS 165.6M
  • SUPX 198.5M
  • IPO Year
  • SLS N/A
  • SUPX 2024
  • Fundamental
  • Price
  • SLS $1.91
  • SUPX $42.84
  • Analyst Decision
  • SLS Strong Buy
  • SUPX
  • Analyst Count
  • SLS 1
  • SUPX 0
  • Target Price
  • SLS $7.00
  • SUPX N/A
  • AVG Volume (30 Days)
  • SLS 1.8M
  • SUPX 507.9K
  • Earning Date
  • SLS 08-12-2025
  • SUPX 09-02-2025
  • Dividend Yield
  • SLS N/A
  • SUPX N/A
  • EPS Growth
  • SLS N/A
  • SUPX N/A
  • EPS
  • SLS N/A
  • SUPX N/A
  • Revenue
  • SLS N/A
  • SUPX $1,978,875.00
  • Revenue This Year
  • SLS N/A
  • SUPX N/A
  • Revenue Next Year
  • SLS N/A
  • SUPX N/A
  • P/E Ratio
  • SLS N/A
  • SUPX N/A
  • Revenue Growth
  • SLS N/A
  • SUPX N/A
  • 52 Week Low
  • SLS $0.77
  • SUPX $2.75
  • 52 Week High
  • SLS $2.27
  • SUPX $44.50
  • Technical
  • Relative Strength Index (RSI)
  • SLS 60.77
  • SUPX 80.78
  • Support Level
  • SLS $1.50
  • SUPX $21.80
  • Resistance Level
  • SLS $1.77
  • SUPX $31.54
  • Average True Range (ATR)
  • SLS 0.11
  • SUPX 4.04
  • MACD
  • SLS 0.04
  • SUPX 1.25
  • Stochastic Oscillator
  • SLS 97.62
  • SUPX 92.69

About SLS SELLAS Life Sciences Group Inc.

SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.

About SUPX Super X AI Technology Limited Ordinary Shares

Super X AI Technology Ltd is a company that specializes in providing high-quality residential and commercial interior design solutions. Through its subsidiaries, SuperX aims to become a technology company dedicated to developing and delivering next-generation digital infrastructure solutions. It is committed to integrating smart technology into every aspect of its offerings, setting new standards for innovation and excellence in the industry.

Share on Social Networks: